Tabelecleucel
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tabelecleucel, covering 2024-11-14 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]